World Media

UK Starts Real-Time Review Of Moderna's COVID-19 Vaccine Candidate

UK Starts Real-Time Review Of Moderna's COVID-19 Vaccine Candidate

The technology, which has yet to produce an approved vaccine, is also used in the COVID-19 vaccine being developed by Pfizer Inc and German partner BioNTech SE.

The selected individuals will be given COVID-19 vaccine.

President Donald Trump and lawmakers of both parties in Congress have spelled out their intention that all Americans will be able to get the vaccine for free. "If we don't go for an emergency licence, our trials should be over by December and then we can maybe launch in India in January subject to the United Kingdom trial also being completed which it's on the verge of being completed", Poonawalla said.

"The Russian Federation has become one of the first countries to apply to World Health Organization for pre-qualification of its vaccine against the novel coronavirus infection", RDIF said in a statement.

She said while the federal government is paying for vaccines, insurers, including Medicare, Medicaid and private plans, have to pay for coverage.

The plans would not be responsible for reimbursing providers to administer the vaccine during this time, CMS said.

The new CMS policy implemented a provision from the CARES Act that covers Americans with private insurance.

It has pumped billions of dollars into numerous pharmaceutical companies in hopes of developing one or more safe and effective COVID-19 vaccines. Already, hundreds of providers across the state have signed on to administer the vaccine, according to Carfrae.

Earlier this month, Medicare administrator Seema Verma said her agency was close to resolving the issue.

Russian Federation has submitted applications to the World Health Organisation (WHO) for accelerated registration and prequalification of its COVID-19 vaccine Sputnik V to make it available globally in a shorter time frame than usual procedures, according to an official statement on Wednesday.

Paramedical staff - all technicians, pharmacist, physiotherapist, radiographer, ward boys, other paramedical staff as well as scientists, research staff, students medical, dental, AYUSH, nursing and paramedical students working in the facilities, support staff and the clerical and administrative staff will also be included in the list, he said. In September, AstraZeneca suspended the clinical trial due to an unexplained illness contracted by a British patient. But even if the company files for emergency authorization by next month, it's unlikely the approval can be granted this year.

"Our job at Medicare is to make sure that these drugs, once they enter the market, they are immediately accessible by the elderly who need them".

"Under current rules, hospitals may qualify for additional "outlier payments", but only when their costs for a particular patient exceed a certain threshold", a CMS release said.